Kaplan-Meier curve showing postprogression survival in patients in the standard regimens arms who did or did not crossover to ide-cel. Postprogression survival in patients in the SRs arm who crossed over∗ vs did not crossover to ide-cel. ∗Based on KM methods. Patients who underwent leukapheresis with or without ide-cel infusion. Postprogression survival was defined as time from PD (IRC adjudicated) to death due to any cause.